Playbook
What should I actually do about multiple sclerosis?
Multiple sclerosis is an immune-driven disease of the brain and spinal cord, about three times more common in women. The modern picture is hopeful: getting diagnosed promptly and starting effective treatment early can meaningfully protect against long-term disability.
Multiple Sclerosis · reviewed July 2026 · 12 cited papers
See a clinician promptly if
- !New vision loss in one eye, or new weakness, numbness, or severe balance problems. These can be an MS relapse or first attack and need prompt neurological assessment, since early diagnosis and treatment matter.
- !A relapse with disabling symptoms. A short steroid course can speed recovery from an acute attack, so timely review helps.
- !Pregnancy or planning pregnancy while on disease-modifying therapy. Relapse risk rebounds after delivery and some drugs are unsafe in pregnancy, so treatment needs coordinating in advance.
Step 1
Is it MS, and which kind?
MS symptoms come and go and can mimic other conditions. These are the patterns that point to MS and the distinction that shapes treatment.
Step 2
What to get checked
Diagnosis combines the clinical picture with MRI and sometimes spinal fluid, using the McDonald criteria. Some tests also guide risk reduction.
MRI of the brain and spinal cord
Shows the lesions and whether disease is spread in space and time, the core of diagnosis and monitoring.
Spinal fluid analysis, when needed
Certain findings can confirm the diagnosis earlier under the current criteria.
Vitamin D level
Low vitamin D is linked to higher MS risk and activity, and it is easy to check and correct.
Step 3
What good treatment looks like
Treatment has three parts: reduce future relapses with disease-modifying therapy, treat acute attacks, and manage symptoms and modifiable risks.
Start effective disease-modifying therapy early
Disease-modifying therapies reduce relapses and disability. Evidence increasingly favors starting a high-efficacy option (such as a B-cell therapy like ocrelizumab) early rather than stepping up slowly, weighed against its risks.
TimelineOngoing treatment; benefit measured over years.
How to get itPrescription, neurology-managed.
CautionsStronger therapies raise infection risk and need screening and monitoring.
Treat acute relapses with steroids
A short course of steroids speeds recovery from a disabling relapse. It does not change the long-term course, and oral and IV steroids work comparably.
How to get itPrescription.
Reduce modifiable risks
Not smoking slows progression, and correcting vitamin D deficiency is sensible. These are concrete, low-risk steps alongside medication.
Exercise and rehabilitation
Structured, tailored exercise reliably improves walking, strength, fitness, and fatigue and is safe. It should be a core part of management, ideally with a physiotherapist and attention to heat sensitivity.
Set your expectations
- MS is highly treatable now, and starting effective therapy early is the best lever against long-term disability.
- Disease-modifying drugs prevent future relapses; they do not undo damage already done, so timing matters.
- Relapses may recover with or without steroids, which speed recovery but do not change the long-term course.
- If you may become pregnant, plan medications in advance, since relapse risk rebounds after delivery.
Step 4
Take this to your doctor
“I have had neurological symptoms that concern me, and I want a prompt assessment for MS and, if I have it, to discuss starting effective treatment early.”
Questions to ask
- Do my MRI and symptoms meet the criteria for MS, and is it relapsing or progressive?
- Am I a candidate for early high-efficacy therapy, and how do its risks compare with the risk of disability?
- Should my vitamin D be checked, and can you help me stop smoking?
- How should we plan treatment around any pregnancy plans?
What to bring
- A timeline of your neurological symptoms and any past episodes
- Copies of prior MRI scans and reports
- Your smoking status and reproductive plans
When to push. Ask for urgent neurology assessment for new vision loss, weakness, or numbness, and for family-planning counseling before conceiving.
Step 5
Where the science is going
Epstein-Barr virus as a cause, and prevention research
A landmark study found that almost everyone who develops MS was infected with Epstein-Barr virus first, making it a likely trigger. This is driving research into EBV vaccines and antivirals aimed at preventing MS, though none is yet proven.
All sources
Every claim above links to peer-reviewed research. Full list below.
- Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria (2018). The Lancet Neurology. doi.org/10.1016/S1474-4422(17)30470-2
- Multiple Sclerosis (2018). The New England Journal of Medicine. doi.org/10.1056/NEJMra1401483
- Sex ratio of multiple sclerosis in Canada: a longitudinal study (2006). The Lancet Neurology. doi.org/10.1016/S1474-4422(06)70581-6
- Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients With Multiple Sclerosis (2019). JAMA Neurology. doi.org/10.1001/jamaneurol.2018.4905
- Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis (2017). The New England Journal of Medicine. doi.org/10.1056/NEJMoa1601277
- Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis (2006). JAMA. doi.org/10.1001/jama.296.23.2832
- Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis (2022). Science. doi.org/10.1126/science.abj8222
- Smoking is a major preventable risk factor for multiple sclerosis (2016). Multiple Sclerosis Journal. doi.org/10.1177/1352458515609794
- Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group (1998). The New England Journal of Medicine. doi.org/10.1056/NEJM199807303390501
- Family planning considerations in people with multiple sclerosis (2023). The Lancet Neurology. doi.org/10.1016/S1474-4422(22)00426-4
- Exercise in patients with multiple sclerosis (2017). The Lancet Neurology. doi.org/10.1016/S1474-4422(17)30281-8
- Corticosteroids or ACTH for acute exacerbations in multiple sclerosis (2000). Cochrane Database of Systematic Reviews. doi.org/10.1002/14651858.CD001331
This playbook is educational and is not medical advice. Hair loss has many causes and individual treatment decisions belong with a clinician who can examine you.